Literature DB >> 10775542

Familial British dementia with amyloid angiopathy: early clinical, neuropsychological and imaging findings.

S Mead1, M James-Galton, T Revesz, R B Doshi, G Harwood, E L Pan, J Ghiso, B Frangione, G Plant.   

Abstract

Familial British dementia with amyloid angiopathy (FBD) is an autosomal dominant condition characterized by a dementia, progressive spastic tetraparesis and cerebellar ataxia with onset in the sixth decade. A point mutation in the BRI gene has been shown to be the genetic abnormality. Genealogical work with the large family originally reported by Worster-Drought and updated by Plant has identified nine generations dating back to the late eighteenth century. The pedigree now includes six living affected patients, 35 historical cases, and 52 descendants at risk of having inherited the disease. A common ancestor has been identified between the large pedigree and a case report of 'familial cerebellar ataxia with amyloid angiopathy'. An autopsy case from a separate family with an identical condition is described but no common ancestor with the large pedigree has been found. Case histories have been researched and updated in each pedigree. Eleven individuals at risk of FBD, aged between 44 and 56 years, agreed to undergo a clinical and neuropsychological assessment along with MRI brain imaging in order to clarify early diagnostic features. Five of the eleven were thought to show early clinical signs of the disease. Neurological examination was abnormal in three, with limb and gait ataxia and mild spastic paraparesis. Three had impaired recognition and recall memory and another had mild impairment of delayed visual recall. All affected individuals had an abnormal MRI of the brain, consisting of deep white-matter hyperintensity (T(2)-weighted scans) and lacunar infarcts, but no intracerebral haemorrhage. The corpus callosum was affected particularly, and in one patient it was severely atrophic.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10775542     DOI: 10.1093/brain/123.5.975

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  16 in total

Review 1.  Young onset dementia.

Authors:  E L Sampson; J D Warren; M N Rossor
Journal:  Postgrad Med J       Date:  2004-03       Impact factor: 2.401

2.  PYROGLUTAMATE FORMATION AT THE N-TERMINI OF ABRI MOLECULES IN FAMILIAL BRITISH DEMENTIA IS NOT RESTRICTED TO THE CENTRAL NERVOUS SYSTEM.

Authors:  Yasushi Tomidokoro; Akira Tamaoka; Janice L Holton; Tammaryn Lashley; Blas Frangione; Tamas Revesz; Agueda Rostagno; Jorge Ghiso
Journal:  Hirosaki Igaku       Date:  2010-07-08

3.  Early onset familial Alzheimer Disease with spastic paraparesis, dysarthria, and seizures and N135S mutation in PSEN1.

Authors:  Leslie A Rudzinski; Rita M Fletcher; Dennis W Dickson; Richard Crook; Michael L Hutton; Jennifer Adamson; Neill R Graff-Radford
Journal:  Alzheimer Dis Assoc Disord       Date:  2008 Jul-Sep       Impact factor: 2.703

Review 4.  Alzheimer's disease pathologic cascades: who comes first, what drives what.

Authors:  Russell H Swerdlow
Journal:  Neurotox Res       Date:  2011-09-13       Impact factor: 3.911

5.  Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia.

Authors:  J L Holton; J Ghiso; T Lashley; A Rostagno; C J Guerin; G Gibb; H Houlden; H Ayling; L Martinian; B H Anderton; N W Wood; R Vidal; G Plant; B Frangione; T Revesz
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

6.  The Familial British Dementia Mutation Promotes Formation of Neurotoxic Cystine Cross-linked Amyloid Bri (ABri) Oligomers.

Authors:  Adam Cantlon; Carlo Sala Frigerio; Darragh B Freir; Barry Boland; Ming Jin; Dominic M Walsh
Journal:  J Biol Chem       Date:  2015-05-08       Impact factor: 5.157

7.  Expression of BRI2 mRNA and protein in normal human brain and familial British dementia: its relevance to the pathogenesis of disease.

Authors:  T Lashley; T Revesz; G Plant; R Bandopadhyay; A J Lees; B Frangione; N W Wood; R de Silva; J Ghiso; A Rostagno; J L Holton
Journal:  Neuropathol Appl Neurobiol       Date:  2008-02-13       Impact factor: 8.090

Review 8.  Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies.

Authors:  Tamas Revesz; Janice L Holton; Tammaryn Lashley; Gordon Plant; Blas Frangione; Agueda Rostagno; Jorge Ghiso
Journal:  Acta Neuropathol       Date:  2009-02-19       Impact factor: 17.088

9.  Abundant pyroglutamate-modified ABri and ADan peptides in extracellular and vascular amyloid deposits in familial British and Danish dementias.

Authors:  Anika Saul; Tammaryn Lashley; Tamas Revesz; Janice Holton; Jorge A Ghiso; Janaky Coomaraswamy; Oliver Wirths
Journal:  Neurobiol Aging       Date:  2012-12-20       Impact factor: 4.673

Review 10.  Tau, prions and Aβ: the triad of neurodegeneration.

Authors:  Lilla Reiniger; Ana Lukic; Jacqueline Linehan; Peter Rudge; John Collinge; Simon Mead; Sebastian Brandner
Journal:  Acta Neuropathol       Date:  2010-05-16       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.